8VC

Type

Venture Capital

Status

Active

Location

Austin, United States

Total investments

437

Average round size

40M

Portfolio companies

274

Rounds per year

48.56

Lead investments

42

Follow on index

0.36

Exits

15

Stages of investment
Seed
Areas of investment
BiotechnologySoftwareFinTechInformation TechnologyArtificial IntelligenceMachine LearningHealth CareSaaSEnterprise SoftwareMedical

Summary

8VC appeared to be the VC, which was created in 2015. The company was established in North America in United States. The main department of described VC is located in the San Francisco.

This organization was formed by Alex Kolicich, Drew Oetting, Jake Medwell, Kimmy Scotti. We also calculated 9 valuable employees in our database.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the 8VC, startups are often financed by Y Combinator, Thrive Capital, Sway Ventures. The meaningful sponsors for the fund in investment in the same round are SV Angel, Lightspeed Venture Partners, Great Oaks Venture Capital. In the next rounds fund is usually obtained by Founders Fund, Menlo Ventures, Emergence.

This 8VC works on 25 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2018. The higher amount of exits for fund were in 2019. The fund is constantly included in 25-48 deals per year. The average startup value when the investment from 8VC is 500 millions - 1 billion dollars.

The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Oscar Health Insurance Co., Flexport, Guardant Health We can highlight the next thriving fund investment areas, such as Biotechnology, SaaS. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Show more

Investor highlights

Industry focus
LogisticsBiotech/Life SciencesHealthcareCloud/InfrastructureGovtech/Legaltech Show 5 more
Stage focus
Seed
Check size
100K — 50M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 880000000
Fund raised date
2023-03-01

Analytics

Total investments
437
Lead investments
42
Exits
15
Rounds per year
48.56
Follow on index
0.36
Investments by industry
  • Software (131)
  • Health Care (78)
  • SaaS (65)
  • Information Technology (63)
  • Biotechnology (62)
  • Show 258 more
Investments by region
  • United States (386)
  • Colombia (7)
  • United Kingdom (9)
  • Canada (6)
  • Israel (5)
  • Show 4 more
Peak activity year
2021
Number of Unicorns
20
Number of Decacorns
21
Number of Minotaurs
6

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Avg. valuation at time of investment
312M
Group Appearance index
0.97
Avg. company exit year
5
Avg. multiplicator
2.64
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Amber Therapeutics 10 Jun 2024 Biotechnology, Therapeutics Early Stage Venture 109M England, London, United Kingdom
QuantAMM 06 Apr 2024 Seed 1M England, London, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.